CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-14 | Radov A. Jeffrey Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2017-02-14 | Radov A. Jeffrey Director | Returned to the company · Stock Option | −115,500 | 0 | ||
| 2017-02-14 | Radov A. Jeffrey Director | Grant or award · Stock Option | +115,500 | 115,500 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −4,000 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +4,000 | 4,000 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −50,000 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −20,000 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −12,500 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +12,500 | 12,500 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −50,000 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −150,000 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +150,000 | 150,000 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Returned to the company · Stock Option | −208,000 | 0 | ||
| 2017-02-14 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +208,000 | 208,000 | ||
| 2017-02-10 | CATELL ROBERT B Director | Grant or award | +10,866 | $3.00 | $33K | 60,866 |
| 2017-02-10 | CATELL ROBERT B Director | Grant or award · Warrant | +10,866 | 10,866 | ||
| 2017-02-10 | Desmarais John M Director | Grant or award | +21,731 | $3.00 | $65K | 476,731 |
Page 28 of 35 · 690 trades